Table 1.
Atherosclerosis | Hypertension | Heart failure | Obesity, T2DM | Chronic kidney disease | |
---|---|---|---|---|---|
Alterations in gut microbiota composition | ↑Lactobacillus5 ↓Roseburiam4 | ↑Firmicutes / Bacteroides ratio67 | ↑Escherichia coli, Klebsiella pneumonia, Streptococcus viridans | ↑Firmicutes36,37,91,93,94 ↓Bacteroides36, 37, 91 | ↑Firmicutes, Proteobacteria and Actinobacteria131 |
Alterations in gut microbiota metabolites | ↑TMAO8, 9 | ↑SCFA180 | ↑TMAO60, 61, 90 | ↑BAs, SCFA, LPS and TMAO98, 172, 182–184 | ↑Indoxyl sulfate, 185,186 p-cresol sulfate, 186,187 ammonia and urea, 188 and TMAO59 |
Proof of concept | Dietary choline/ carnitine ↑TMAO8 DMB suppress TMA/TMAO.65 ↑TMAO associated with unstable plaque and MACE. 22,63,189 Cecal microbial transplantation transmits disease susceptibility.145 |
Infusion of AngII/TMAO associated with ↑blood pressure 190 | ↑gut permeability88 ↑TMAO was associated with LV remodelling and poor prognosis60,61,90 |
↑insulin sensitivity related to vancomycin treatment99 ↑Leptin, GLP1,103–106 PYY102, 105, 106 ↑TMAO was associated with glycemic control. 191 |
Ammonia disrupt the gut epithelial tight junction131 Elevated TMAO was associated with decreased renal function, renal fibrosis and mortality.59–61,192 |
Interventions | Diet intervention: ↑Bacteroides and Proteobacteria, ↓Firmicutes 193 Probiotics: ↑LV hypertrophy53 Probiotics: ↑SCFA 168 |
Diet intervention: high fiber diet is associated with ↓blood pressure.159 | Diet: High fiber diet is associated with ↓cardiac hypertrophy and fibrosis.159 Probiotics: attenuate heart failure after myocardial infarction.53 |
FMT: improve insulin resistance99, 100 and Roseburia.37, 93 Bariatric surgery is associated with ↑BAs and GLP-1120–122 Probiotics: ↑insulin secretion166 ↓body weight and adipose tissue mass172–175 |
Probiotics: ↓dimethylamine and nitrosodimithylamine.167 |
T2DM = type 2 diabetes mellitus, TMAO = trymethylamine N-oxide, SCFA = short chain fatty acid, BA = bile acid, LPS = lipopolysaccharide, DMB = 1,3 dimethylbutanol, MACE = major adverse cardiac event, AngII = angiotensin II, LV = left ventricular, GLP-1 = glucagon-like peptide 1, PYY = peptide YY, FMT = fecal microbiota transplantation.